Lung Cancer

1

Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy

Vassalou, Helen, Stathopoulos, Efstathios, Fiolitaki, Georgia, Koutsopoulos, Anastasios, Voutsina, Alexandra, Georgoulias, Vassilis, Mavroudis, Dimitris

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 900 KB

english, 2013

2

Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma

Iuchi, T., Shingyoji, M., Sakaida, T., Hatano, K., Nagano, O., Itakura, M., Kageyama, H., Yokoi, S., Hasegawa, Y., Kawasaki, K., Iizasa, T.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 973 KB

english, 2013

3

Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients

Vallée, Audrey, Marcq, Marie, Bizieux, Acya, Kouri, Claude El, Lacroix, Hervé, Bennouna, Jaafar, Douillard, Jean-Yves, Denis, Marc G.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 264 KB

english, 2013

4

Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer

Mazzoni, Francesca, Cecere, Fabiana Letizia, Meoni, Giulia, Giuliani, Costanza, Boni, Luca, Camerini, Andrea, Lucchesi, Sara, Martella, Francesca, Amoroso, Domenico, Lucherini, Elisa, Torricelli, Fran

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 598 KB

english, 2013

5

Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature

Ashworth, Allison, Rodrigues, George, Boldt, Gabriel, Palma, David

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 804 KB

english, 2013

6

Genetic alterations defining NSCLC subtypes and their therapeutic implications

Pikor, Larissa A., Ramnarine, Varune R., Lam, Stephen, Lam, Wan L.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 2.50 MB

english, 2013

7

Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases

Hsiao, Shih-Hsin, Chung, Chi-Li, Chou, Yu-Ting, Lee, Hsin-Lun, Lin, Sey-En, Liu, H. Eugene

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 684 KB

english, 2013

8

Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines

Shirsath, Nitesh, Rathos, Maggie, Chaudhari, Umesh, Sivaramakrishnan, H., Joshi, Kalpana

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 2.35 MB

english, 2013

9

Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: A multicenter analysis

Lococo, F., Cesario, A., Okami, J., Cardillo, G., Cavuto, S., Tokunaga, T., Apolone, G., Margaritora, S., Granone, P.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1009 KB

english, 2013

10

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study

Berghmans, T., Ameye, L., Willems, L., Paesmans, M., Mascaux, C., Lafitte, J.J., Meert, A.P., Scherpereel, A., Cortot, A.B., CsToth, I., Dernies, T., Toussaint, L., Leclercq, N., Sculier, J.P.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 958 KB

english, 2013

11

Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status

Minami, Seigo, Kijima, Takashi, Hamaguchi, Masanari, Nakatani, Takeshi, Koba, Taro, Takahashi, Ryo, Takeuchi, Yoshiko, Kida, Hiroshi, Nagatomo, Izumi, Yamamoto, Suguru, Tachibana, Isao, Komuta, Kiyosh

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 700 KB

english, 2013

12

Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer

Sigel, Keith, Lurslurchachai, Linda, Bonomi, Marcelo, Mhango, Grace, Bergamo, Cara, Kale, Minal, Halm, Ethan, Wisnivesky, Juan

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 471 KB

english, 2013

13

A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment

Nishino, K., Imamura, F., Morita, S., Mori, M., Komuta, K., Kijima, T., Namba, Y., Kumagai, T., Yamamoto, S., Tachibana, I., Nakazawa, Y., Uchida, J., Minami, S., Takahashi, R., Yano, Y., Okuyama, T.,

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 873 KB

english, 2013

14

Editorial Board

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 63 KB

english, 2013

15

Combination of arsenic trioxide and chemotherapy in small cell lung cancer

Zheng, Chun-yan, Lam, Sze-kwan, Li, Yuan-yuan, Fong, Bonnie Mei-wah, Mak, Judith Choi-wo, Ho, James Chung-man

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 2.29 MB

english, 2013

16

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Ciuleanu, T., Tsai, C.-M., Tsao, C.-J., Milanowski, J., Amoroso, D., Heo, D.S., Groen, H.J.M., Szczesna, A., Chung, C.-Y., Chao, T.-Y., Middleton, G., Zeaiter, A., Klingelschmitt, G., Klughammer, B.,

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 718 KB

english, 2013

17

Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study

Mazières, Julien, Brugger, Wolfram, Cappuzzo, Federico, Middel, Peter, Frosch, Alice, Bara, Ilze, Klingelschmitt, Gaelle, Klughammer, Barbara

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1.18 MB

english, 2013

19

LKB1 mutant in a KRAS activated adenocarcinoma of the lung associated with Peutz–Jeghers syndrome: A case report

Zaba, O., Holbe, D., Aretz, S., Grohé, C.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 502 KB

english, 2013

20

Evaluation of the Simplified Comorbidity Score (Colinet) as a prognostic indicator for patients with lung cancer: A cancer registry study

Ball, David, Thursfield, Vicky, Irving, Louis, Mitchell, Paul, Richardson, Gary, Torn-Broers, Yvonne, Wright, Gavin, Giles, Graham

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 442 KB

english, 2013

21

Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinib

Tsai, Chun-Ming, Chen, Jen-Ting, Chiu, Chao-Hua, Lai, Chun-Liang, Hsiao, Shih-Yin, Chang, Kuo-Ting

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1.48 MB

english, 2013

22

Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy

Lee, Shin Yup, Kang, Hyo-Gyoung, Yoo, Seung Soo, Kang, Ye Rim, Choi, Yi Young, Lee, Won Kee, Choi, Jin Eun, Jeon, Hyo-Sung, Shin, Kyung Min, Oh, In Jae, Kim, Kyu Sik, Lee, Jaehee, Cha, Seung Ick, Kim,

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 992 KB

english, 2013

23

Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: The potential risk of extensive radiation pneumonitis

Yamaguchi, Shinsaku, Ohguri, Takayuki, Ide, Satoru, Aoki, Takatoshi, Imada, Hajime, Yahara, Katsuya, Narisada, Hiroyuki, Korogi, Yukunori

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 941 KB

english, 2013

24

Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib

Gautschi, Oliver, Peters, Solange, Zoete, Vincent, Aebersold-Keller, Franziska, Strobel, Klaus, Schwizer, Bernhard, Hirschmann, Astrid, Michielin, Olivier, Diebold, Joachim

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1008 KB

english, 2013

25

Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma

Watanabe, Satoshi, Sone, Takashi, Matsui, Tomoharu, Yamamura, Kenta, Tani, Mayuko, Okazaki, Akihito, Kurokawa, Koji, Tambo, Yuichi, Takato, Hazuki, Ohkura, Noriyuki, Waseda, Yuko, Katayama, Nobuyuki,

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1.24 MB

english, 2013

26

Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: Predictors of use and association with toxicities

Shirvani, Shervin M., Jiang, Jing, Gomez, Daniel R., Chang, Joe Y., Buchholz, Thomas A., Smith, Benjamin D.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 869 KB

english, 2013

27

Acute kidney injury following crizotinib administration for non-small-cell lung carcinoma

Gastaud, Lauris, Ambrosetti, Damien, Otto, Josiane, Marquette, Charles-Hugo, Coutts, Michael, Hofman, Paul, Esnault, Vincent, Favre, Guillaume

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1.11 MB

english, 2013

28

Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial

Hocking, William G., Tammemagi, Martin C., Commins, John, Oken, Martin M., Kvale, Paul A., Hu, Ping, Ragard, Lawrence R., Riley, Tom L., Pinsky, Paul, Beck, Thomas M., Prorok, Philip C.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 474 KB

english, 2013

29

Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6

Abulaiti, Abulimiti, Shintani, Yasushi, Funaki, Soichiro, Nakagiri, Tomoyuki, Inoue, Masayohi, Sawabata, Noriyoshi, Minami, Masato, Okumura, Meinoshin

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 3.11 MB

english, 2013

30

Imaging in pleural mesothelioma: A review of the 11th International Conference of the International Mesothelioma Interest Group

Armato, Samuel G., Labby, Zacariah E., Coolen, Johan, Klabatsa, Astero, Feigen, Malcolm, Persigehl, Thorsten, Gill, Ritu R.

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1.62 MB

english, 2013

31

Serological investigation of the clinical significance of fascin in non-small-cell lung cancer

Teng, Yu, Xu, Shaofa, Yue, Wentao, Ma, Li, Zhang, Lina, Zhao, Xiaoting, Guo, Yinan, Zhang, Chunyan, Gu, Meng, Wang, Yue

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 802 KB

english, 2013

32

Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis

Chen, Yan, Wang, Mengzhao, Zhong, Wei, Zhao, Jing

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1.65 MB

english, 2013

33

Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors

Sun, Jong-Mu, Ahn, Myung-Ju, Choi, Yoon-La, Ahn, Jin Seok, Park, Keunchil

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 590 KB

english, 2013

34

Assessment of palliative care for advanced non-small-cell lung cancer in France: A prospective observational multicenter study (GFPC 0804 study)

Vergnenègre, Alain, Hominal, Stéphane, Tchalla, Achille Edem, Bérard, Henri, Monnet, Isabelle, Fraboulet, Gislaine, Baize, Nathalie, Audigier-Valette, Clarisse, Robinet, Gilles, Oliviero, Gérard, Le C

Journal:

Lung Cancer

Year:

2013

Language:

english

File:

PDF, 494 KB

english, 2013

Volume 82; Issue 2

Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy

Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma

Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients

Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer

Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature

Genetic alterations defining NSCLC subtypes and their therapeutic implications

Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases

Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines

Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: A multicenter analysis

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study

Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status

Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer

A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment

Editorial Board

Combination of arsenic trioxide and chemotherapy in small cell lung cancer

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Contents

Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study

LKB1 mutant in a KRAS activated adenocarcinoma of the lung associated with Peutz–Jeghers syndrome: A case report

Evaluation of the Simplified Comorbidity Score (Colinet) as a prognostic indicator for patients with lung cancer: A cancer registry study

Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinib

Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy

Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: The potential risk of extensive radiation pneumonitis

Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib

Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma

Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: Predictors of use and association with toxicities

Acute kidney injury following crizotinib administration for non-small-cell lung carcinoma

Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial

Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6

Imaging in pleural mesothelioma: A review of the 11th International Conference of the International Mesothelioma Interest Group

Serological investigation of the clinical significance of fascin in non-small-cell lung cancer

Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis

Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors

Assessment of palliative care for advanced non-small-cell lung cancer in France: A prospective observational multicenter study (GFPC 0804 study)